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Abstract 
Background: Si‑Wu‑Tang (SWT) is used to treat various gynecological disorders in Chinese medicine. This study 
investigated the antioxidant and physiological effects of SWT on the skin and liver in healthy adults.
Methods: This randomized, crossover, double‑blind, placebo‑controlled clinical trial was conducted at Chung Shan 
Medical University Hospital in December 2008. Participants with uncontrolled diabetes, heart disease, liver disease, 
kidney disease, cancer, and pregnancy were excluded. Sixty healthy volunteers taking no medications were recruited 
from the community based on the results of their medical history questionnaires and biochemical analyses to confirm 
their health status. The participants were assigned to two groups: one group drank 125 mL of placebo (n = 30) and 
the other drank SWT (n = 30) for six continuous days per month for 6 months. The placebo and SWT were then 
switched between the groups after a 1‑month washout period. Anthropometric measurements (body weight, body 
fat, and body mass index) were performed and fasting blood samples were drawn for various biochemical assays at 
1, 3, 6, 10 and 13 months. Abdominal ultrasound and skin examinations were performed at 1, 6 and 13 months. The 
skin examinations involved assessment of skin roughness, sebum content, hydration, surface water loss, erythema, 
melanin index, and elasticity on the face (sunlight‑exposed sites: middle of ear and nose) and inner arm (sunlight‑
unexposed sites: center of wrist and elbow joint).
Results: Administration of SWT significantly increased the antioxidant index (P = 0.001) and antioxidant enzymes 
activities (P = 0.001) from baseline to month 6. SWT also suppressed the concentration of serum lipids (triglycerides, 
P = 0.01; high‑density lipoprotein cholesterol, P = 0.23; low‑density lipoprotein cholesterol, P = 0.48) and hepatic 
marker enzymes (glutamic pyruvic transaminase, P = 0.76; glutamic oxaloacetic transaminase, P = 0.65) when com‑
pared with the placebo group. Abdominal ultrasound in the SWT group revealed a positive impact of SWT on mild 
fatty liver, gallstones, and mild splenomegaly. Moreover, SWT intake concomitantly elevated erythema (P = 0.011) and 
markedly lowered skin surface water loss (P = 0.016), sebum content (P = 0.021), and wrinkles (P = 0.024).
Conclusions: Oral administration of SWT for 6 months improved the antioxidant level and positively regulated the 
lipid profile, liver function, and skin integrity and texture.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
The therapeutic essence of Chinese medicine (CM) can 
be attributed to multiple elements rather than just one 
in the product used [1]. Si-Wu-Tang (SWT) is a CM 
formula comprising four different medicinal herbs: 
Radix Paeoniae Alba (bai shao yao), Rhizoma Ligusticum 
Chuanxiong (chuan xiong), Radix Angelica Sinensis (dang 
gui), and Radix Rehmanniae Preparata (shu di huang) 
[2]. SWT is widely used for the treatment of gynecologi-
cal disorders such as menstrual discomfort, climacteric 
syndrome, dysmenorrheic and other estrogen-related 
diseases [3], cutaneous diseases [4], and menstrual 
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discomfort [5]. Several preclinical (in vitro) studies of 
SWT have demonstrated antioxidative, anti-inflamma-
tory, antiaging, antibacterial, and antipruritic activities 
[6, 7].
The major bioactive components in these four herbs 
include phenolics, phthalides, alkaloids, terpene glyco-
sides, and iridoid glycosides. Some major constituents 
are gallic acid, paeoniflorin, senkyunolide A, ferulic 
acid, Z-ligustilide, butylphthalide, sodium ferulate, and 
catalpol [3]. Among these compounds, ferulic acid, pae-
oniflorin, and Z-ligustilide in SWT exhibited antioxida-
tive, antimutagenic, anti-inflammatory, vasodilative, and 
antiallergic effects [8–10]. Sodium ferulate in A. sinensis 
and Lignsticum chuangxiong of SWT has lowered the 
oxidation process and lipid levels in various animal mod-
els [11, 12]. Additionally, SWT is rich in organic acids, 
amino acids, polysaccharides, vitamins, and minerals 
such as magnesium, calcium, phosphorus, and iron [13].
Liver cells (hepatocytes) metabolize toxins such as 
alcohol and drugs into their inactive metabolites. Hepat-
ocytes are extremely prone to peroxide (free radical) for-
mation because of their higher metabolic rate. These free 
radicals are effectively eliminated by antioxidants, espe-
cially glutathione peroxidase (GPx). GPx plays a major 
role in the reductive detoxification of peroxides in hepat-
ocytes [14]. A decreased antioxidant level may lead to 
oxidative stress and eventual hepatic dysfunction. Several 
reports have proven that hepatic dysfunction might con-
tribute to various dermal disorders such as dermatitis, 
eczema, psoriasis, acne, and boils or rashes secondary to 
decreased detoxification (excessive toxin buildup in skin) 
and elevated inflammation and oxidative stress [15, 16]. 
Hence, this study was designed to investigate the antioxi-




Folin–Ciocalteu phenol reagent, sodium hydroxide, 
sodium nitrite, hydrochloric acid, 6-hydroxy-2,5,7,8-tetra-
methylchromane-2-carboxylic acid (Trolox), hydrogen 
peroxide, sodium dihydrogen phosphate, and trichloro-
acetic acid were purchased from Sigma (St. Louis, MO, 
USA).
SWT and placebo
Commercially available SWT and placebo as an oral sus-
pension (glass vial) were provided by Standard Foods 
Corporation (Taipei, Taiwan). Each vial contained 
125  mL of SWT (Radix P. Alba, Rhizoma L. Chuanx-
iong, Radix A. Sinensis, and Radix R. Preparata with cin-
namon twig, rose hip extract, sucrose, vitamin C, malic 
acid, citric acid, and gelatin) or placebo (simulated SWT 
flavor with herb-rinsed water and sucrose solution). Both 
sample vials were indistinguishably packaged with a simi-
lar color, flavor, size, and shape.
Participants
This randomized, crossover, double-blind, placebo-
controlled clinical trial was conducted in Chung Shan 
Medical University Hospital. The trial was carried out in 
accordance with the declaration of Helsinki and subse-
quent revisions and approved by the Institutional Review 
Board  (IRB) of Chung Shan Medical University Hospi-
tal, Taichung, Taiwan (CSMUHCS08008) and registered 
with clinicaltrials.gov (NCT02634242) (Additional file 1). 
Written informed consent was received from all partici-
pants before enrollment (Additional file  2). Taking into 
account an expected dropout rate of approximately 25 % 
and the crossover design, the required sample size (95 % 
CI, α = 0.05) was 60 participants (30 participants in each 
group) [17]. All participants (aged 20–80  years) were 
enrolled in the present experiment via advertisements 
displayed in public places.
The participants were requested to avoid using medi-
cations or supplements during the intervention. They 
could withdraw from the study at any time if desired. 
The exclusion criteria were a history of smoking, alco-
holism, pregnancy or lactation, chronic diseases, and 
hepatic or renal dysfunction. A physical examination 
was performed in the 60 voluntary participants at the 
beginning of the study, and they were segregated into 
two groups of 30 participants in each (five male and 25 
female): those who drank 125  mL of placebo and those 
who drank SWT for 6 days per month for 6 months. The 
placebo and SWT were switched between the two groups 
after a 1-month washout period. Anthropometric analy-
ses of body weight, body fat, and body mass index were 
performed at 1, 3, 6, 10 and 13  months. The SWT and 
placebo vials were labeled with the participant number 
by an electrical randomization method [17]. The average 
percentage intake of SWT or placebo was 88.47 % at the 
end of the experiment based on the participants’ records. 
During the crossover study, three and two female partici-
pants in the placebo and SWT groups, respectively, were 
excluded from the study because of an unwillingness to 
cooperate. Thus, the present study was performed with 
27 and 28 participants in the placebo and SWT group, 
respectively (n = 55).
Blood sampling
At baseline (months 1 and 7), the middle time point 
(months 3 and 10), and the end of each intervention 
period (months 6 and 13), fasting blood samples were 
collected in an EDTA-coated vacuum tube, and plasma 
was separated by centrifugation (Supercentrifuge 1K15; 
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Sigma) at 1500×g. Blood samples were isolated after sep-
arating the intermediate film, and the settled portion was 
washed with isotonic saline and centrifuged at 1500×g to 
obtain the erythrocytes for assaying antioxidant enzymes. 
All samples were stored at −80 °C until analyses.
Abdominal ultrasonic examination was performed at 
month 1, 6 and 13 at Chung Shan Medical University 
Hospital, Taichung, Taiwan with the help of an experi-
enced gastroenterology physician (Dr. Chen Ziyan).
Various oxidative indexes
The total antioxidant capacity (TEAC) [18, 19], total thio-
barbituric acid reactive substances (TBARS) [20], and 
glutathione content [21] in plasma were determined by 
previously reported methods.
Antioxidative enzymes
Superoxide dismutase (SOD) activity was determined 
with the Ransod SD 125 kit (Randox Labs, Crumlin, UK), 
GPx and glutathione reductase (GR) activity were deter-
mined with the Ransel RS 504 kit (Randox Labs, Crumlin, 
UK), and catalase (CAT) activity was measured by Aebi 
[22]. The red blood cell protein content was determined 
based on the biuret reaction of the BCA kit from Thermo 
Fisher Scientific (MA, USA).
Serum lipids and hepatic markers
The serum concentrations of total cholesterol (TC), 
triglycerides (TG), and high-density lipoprotein cho-
lesterol (HDL-c) were measured by commercially avail-
able lipid profile kits (CHODPAP for TC, GPO-PAP 
for TG, and a precipitation method for HDL-c; Roche 
Diagnostics, Mannheim, Germany) on a Hitachi 747 
autoanalyzer. Low-density lipoprotein cholesterol 
(LDL-c) was calculated by the Friedewald equation. 
The plasma glutamic oxaloacetic transaminase (GOT) 
and glutamic pyruvic transaminase (GPT) concentra-
tions were measured by AppliedBio assay kits (Hercu-
les, CA, USA).
Skin examination
A multifunctional skin detector (MPA 580; Courage and 
Khazaka Electronic GmbH, Cologne, Germany) and skin 
roughness analyzer (VD 300; Courage and Khazaka Elec-
tronic GmbH) were used to detect the biophysical char-
acteristics of skin in the face and arm regions. No skin 
care products were applied to the measured sites for at 
least 24  h prior to the measurements. The skin sebum 
content, hydration, surface water loss, erythema, melanin 
index, and elasticity were measured with the following 
respective probes: Sebumeter, Corneometer, TEWAm-
eter, Mexameter, and Cutometer (Courage and Khazaka 
Electronic GmbH).
The Sebumeter SM 815 utilizes the difference in light 
intensity via a plastic strip to indicate the quantity of 
absorbed sebum. The sebum level is expressed as μg/cm2 
[23]. Skin hydration was measured by Corneometer CM 
825, which uses the high dielectric constant of water 
to evaluate the water-related changes in the electrical 
capacitance of the skin. It displays hydration measure-
ments in system-specific arbitrary units [24]. A melanin 
index is calculated by the Mexameter MX 18 from the 
strength of the absorbed and reflected light at 660 and 
880 nm, respectively. Erythema is processed similarly at 
568 and 660 nm, respectively [25]. The measurement of 
cutaneous water loss by TEWAmeter TM 300 was ana-
lyzed based on the diffusion in an open chamber and is 
expressed as g/m2/h [26]. The Cutometer MPA 580 pulls 
the targeted skin into the probe with controlled vacuum 
pressure [27]. Skin wrinkles were measured using a Visi-
oscan VC 98 (Courage and Khazaka Electronic GmbH). 
In brief, two points were measured: one at the middle of 
the nose and right ear, and the other at the middle of the 
wrist and inner elbow joint of right hand. All participants 
were instructed to wash and clean their face and arm, and 
then rested calmly for 30 min in a room kept at 20 ± 2 °C 
and a relative humidity of 50 ± 2 % before testing.
Statistical analysis
The results are expressed as a mean ± standard deviation. 
The paired t test was employed to compare differences 
within the same group (baseline vs. end of treatment), 
and Student’s t test was used to compare differences 
between the experimental (SWT) and control (placebo) 
groups. All variables were analyzed via one-way analysis 
of variance with the post doc least-significant differences 
test. A P  <  0.05 was considered statistically significant. 
The Statistical Package for the Social Sciences (SPSS) ver-
sion 17.0 (Chicago, IL, USA) was used for analysis.
Results and discussion
A crossover design was chosen for the present inves-
tigation because of its numerous advantages such as 
decreased confounding covariants (because the same 
participants ingested both SWT and placebo) as well as 
statistically effective during chronic condition [28]. Based 
on our literature survey, a 1-month wash-out period was 
adopted for the present study to suppress the carry-over 
effect. A flowchart of the present study is illustrated in 
Fig.  1. The anthropometric parameters in the placebo 
and SWT groups are presented in Table  1. At baseline, 
the body weight, body fat, and body mass index were 
within the normal range in both the placebo and SWT 
groups. There were no significant differences in any of 
the anthropometric parameters between the placebo and 
SWT groups at the end of the intervention.
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Antioxidants interact with free radicals and stabilize by 
donating their electrons or protons. If untreated, these 
free radicals can cause various chronic diseases [29]. 
Table  2 shows the plasma oxidative indexes including, 
TEAC, glutathione (GSH) concentration, and TBARS in 
the placebo- and SWT-treated participants. The TEAC 
reflects the relative ability of hydrogen or electron-donat-
ing antioxidants to scavenge the 2,2′-azino-bis 3-ethylb-
enzothiazoline-6-sulphonic acid (ABTS) radical cation 
compared with that of Trolox. Treatment with SWT 
for 6 months substantially increased the levels of TEAC 
(0.35–0.59  µM; P  =  0.001) and GSH (14.19–14.35  µM; 
P  =  0.88), whereas the TBARS level (1.40–0.68  µM; 
P  =  0.001) was lower than that in the baseline period; 
additionally, notable changes were found between the 
SWT and placebo groups. SWT comprises four medici-
nal plants with numerous active components including 
gallic acid, paeoniflorin, ferulic acid, and Z-ligustilide, 
which contain numerous OH groups that scavenge free 
radicals through electron delocalization [6]. Liu et  al. 
[30] reported that polysaccharide from A. sinensis could 
directly scavenge oxygen-derived free radicals in colonic 
tissues of rats with colitis.
The antioxidant defense system consists of endogenous 
antioxidants SOD, CAT, GPx, and GR. SOD catalyzes the 
dismutation of superoxide into hydrogen peroxide and 
water molecules. After the decomposition of hydrogen 
peroxide by GPx at the expense of GSH, the GR-catalyzed 
Fig. 1 Flow chart of present study
Table 1 The anthropometric parameters in  placebo 
and SWT treated healthy subjects
Values were expressed as mean ± SD (n = 55). Data within the same column 
of each group sharing different superscript letters were significantly different 
(p < 0.05)
BMI body mass index
Group Weight (kg) Body fat (%) BMI (kg/m2)
Baseline
 Placebo 57.46 ± 9.43a 29.23 ± 5.82a 22.29 ± 3.18a
 SWT 57.45 ± 9.58a 29.27 ± 5.77a 22.35 ± 3.19a
3rd month
 Placebo 57.74 ± 9.80a 29.47 ± 5.91a 22.39 ± 3.28a
 SWT 57.70 ± 9.48a 29.15 ± 5.70a 22.44 ± 3.21a
6th month
 Placebo 57.70 ± 9.28a 29.32 ± 6.09a 22.32 ± 3.46a
 SWT 57.41 ± 9.67a 29.25 ± 5.77a 22.07 ± 3.43a
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regeneration of GSH from its oxidized form can sustain 
the GSH-dependent oxy-radical scavenging activity [31].
The antioxidant enzymes evaluated in this study (SOD, 
CAT, GPx, and GR in the erythrocytes of the placebo- 
and SWT-treated participants) are epitomized in Table 3. 
No notable changes were found from baseline to month 
6 in the placebo-treated group. However, treatment 
with 125 mL of SWT showed a marked escalation in the 
levels of SOD (1478.12–1812.47  IU/g Hb; P  =  0.001), 
CAT (565.82–803.32  IU/g Hb; P =  0.001), GPx (51.03–
52.59 IU/g Hb; P = 0.46), and GR (10.51–11.93 IU/g Hb; 
P = 0.02) between baseline and the end of the treatment 
(month 6). Meanwhile, significant changes were also 
noted between the SWT and placebo groups at month 6.
Nuclear factor erythroid 2-related factor 2 (Nrf2) 
by Z-ligustilide was involved in the antioxidant activ-
ity in the SWT group. Activation of Nrf2 triggered the 
downstream antioxidant genes (SOD, CAT) and thereby 
enhanced antioxidant enzyme levels [32]. Additionally, 
the polyphenolics and numerous phytochemical con-
stituents present in SWT might have elevated the levels 
of antioxidant enzymes by their free radical quenching 
ability [7]. Hou et  al. [33] reported that treatment with 
L. chuanxiong and A. sinensis showed a better protection 
against hydrogen peroxide-induced endothelial damage 
by suppressing reactive oxygen species production. Fur-
thermore, trace elements (calcium, magnesium, and sele-
nium) in SWT act as cofactors to antioxidant enzymes 
[34].
Lipids are metabolized and regulated by hepatocytes. 
Any changes in the hepatic lipid status could directly 
reflect the serum lipid status. Although they are not 
major hepatic markers, lipids are still effective markers 
with which to determine whether SWT impacts physi-
ological changes in hepatic tissue by estimating the lipid 
profile in serum. Table  4 shows the lipid profiles in the 
serum of the placebo and SWT groups. Supplementation 
with SWT for 6 months resulted in a significant decline 
in the levels of TG (102.12–85.89  mg/dL; P  =  0.01) 
with a slight decrement in the level of LDL-c (113.05–
112.84  mg/dL; P  =  0.48), whereas the level of HDL-c 
was concomitantly improved when compared with the 
baseline value (57.52–59.13 mg/dL; P = 0.23). However, 
no marked changes were observed in the TC level. These 
Table 2 Various plasma oxidative indexes in placebo and SWT treated healthy subjects
Values were expressed as mean ± SD (n = 55). Data within the same column of each group bearing different superscript letters were significantly different (p < 0.05)
* Student’s t test was used to assess statistical significance between placebo and Si Wu Tang (SWT)
Group TEAC (µM/mL) p value* TBARS (μM/L) p value* GSH (μM/L) p value*
Baseline
 Placebo 0.34 ± 0.07a 0.82 1.43 ± 0.47a 0.87 14.18 ± 2.30b 0.67
 SWT 0.35 ± 0.07b 1.40 ± 0.44a 14.19 ± 2.48b
3rd month
 Placebo 0.34 ± 0.04a 0.001 1.42 ± 0.43a 0.001 14.19 ± 2.79a 0.83
 SWT 0.40 ± 0.07b 0.83 ± 0.28b 14.31 ± 2.72a
6th month
 Placebo 0.35 ± 0.03a 0.001 1.45 ± 0.32a 0.001 14.16 ± 2.85a 0.88
 SWT 0.59 ± 0.06a 0.68 ± 0.23c 14.35 ± 2.94b
Table 3 Erythrocyte antioxidative enzymes in placebo and SWT treated healthy subjects
Values were expressed as mean ± SD (n = 55). Data within the same column of each group bearing different superscript letters were significantly different (p < 0.05)
* Student’s t test was used to assess statistical significance between placebo and Si Wu Tang (SWT)
Group SOD (IU/g Hb) p value* CAT (IU/g Hb) p value* GPx (IU/g Hb) p value* GR (IU/g Hb) p value*
Baseline
 Placebo 1475.85 ± 155.91a 0.59 562.82 ± 91.86a 0.97 51.04 ± 8.61a 0.99 10.45 ± 1.69a 0.86
 SWT 1478.86 ± 230.38c 565.13 ± 89.02c 51.02 ± 8.90b 10.54 ± 1.80b
3rd month
 Placebo 1471.12 ± 183.53a 0.01 553.14 ± 66.28a 0.001 51.08 ± 6.99a 0.63 10.90 ± 1.98a 0.01
 SWT 1572.01 ± 238.24b 677.61 ± 98.83b 51.82 ± 8.97a 11.94 ± 2.34a
6th month
 Placebo 1475.67 ± 165.34a 0.001 569.36 ± 72.39a 0.001 51.61 ± 7.05a 0.46 10.86 ± 2.01a 0.02
 SWT 1812.47 ± 343.74a 803.32 ± 93.10a 52.59 ± 6.86ab 11.93 ± 2.66a
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outcomes indicate that SWT did not change the cho-
lesterol levels; instead, it substantially changed the TG 
levels, probably owing to the presence of paeoniflorin 
in SWT. Paeoniflorin works as an inhibitor of pancre-
atic lipase and thereby lowers TG levels [35]. Our results 
are consistent with those of Li et al. [36], who concluded 
that oral administration of polysaccharides from A. sin-
ensis significantly reduced the TG and LDL-c levels and 
improved the HDL-c level in STZ-induced diabetic rats. 
Moreover, sodium ferulate in A. sinensis and L. chuangx-
iong lowered lipid levels in various animal models [11, 
12].
The serum GOT and GPT activities are reliable indi-
cators of liver injury [37]. The concentrations of these 
hepatic markers in the placebo and SWT groups of the 
present study are shown in Table  5. In a comparison 
of the baseline and end-of-intervention values in the 
SWT group, no significant changes were noted in the 
GOT concentration (20.67–20.33 U/L; P =  0.65), but a 
slight decrease was observed in the GPT concentration 
(19.00–18.51 U/L; P  =  0.76). This indicates that SWT 
can improve hepatic function by lowering hepatic marker 
enzymes. Wang et al. [38] concluded that treatment with 
Radix P. Rubra and Radix P. Alba significantly attenuated 
CCl4-induced acute liver injury in a rat model. Angelica 
sinensis exhibited a hepatoprotective effect against hepa-
totoxicity induced by CCl4 attributing to its antioxidant 
activity [39].
The abdominal ultrasonic examination findings in the 
placebo- and SWT-treated participants are shown in 
Fig. 2. The examination findings revealed mild fatty liver 
(Fig.  2a), gallbladder stones (Fig.  2b), and splenomegaly 
(Fig.  2c) in participant nos. 3, 9 and 28, respectively, at 
baseline. Treatment with SWT for 6 months in these par-
ticipants resulted in normal examination findings with no 
signs of fatty liver (Fig. 2d), gallbladder stones (Fig. 2e), or 
splenomegaly (Fig. 2f ). SWT improved hepatic function 
by reducing reactive oxygen species, thereby lowering 
the lipid profile parameters and hepatic damage as well 
as normalizing various abnormal conditions such as fatty 
liver, gallbladder stones, and splenomegaly owing to its 
free radical quenching activity.
The skin plays a crucial role in protecting the body 
from physical and chemical factors and moisture loss 
[40]. As discussed earlier, the liver is a major metabolic 
organ involved in detoxification with the help of GSH, 
GPx, GST, and GR. Decreases in the antioxidant levels 
in liver may lead to hepatic dysfunction. Several reports 
have proven that hepatic dysfunction can lead to various 
dermal disorders such as eczema, psoriasis, acne, boils, 
or rashes [15, 16]. The present study investigated the 
physiological correlation between hepatic and dermal 
organs with respect to antioxidation in healthy subjects.
Skin elasticity, moisture, surface water loss, sebum 
content, melanin, erythema, and wrinkles were analyzed 
to determine skin changes in the face and arm regions. 
Table 6 shows the results of the skin examination in the 
Table 4 The lipid profile in plasma of placebo and SWT treated healthy subjects
Values were expressed as mean ± SD (n = 55). Data within the same column of each group bearing different superscript letters were significantly different (p < 0.05)
* Student’s t test was used to assess statistical significance between placebo and Si Wu Tang (SWT)
Group TG (mg/dL) p value* TC (mg/dL) p value* HDL-c (mg/dL) p value* LDL-c (mg/dL) p value*
Baseline
 Placebo 100.22 ± 25.60a 0.81 192.85 ± 38.05a 0.95 57.02 ± 11.21a 0.87 114.98 ± 32.99a 0.69
 SWT 102.12 ± 28.60a 192.05 ± 35.34a 57.52 ± 10.25b 113.05 ± 31.23a
3rd month
 Placebo 97.56 ± 14.96a 0.01 191.71 ± 34.63a 0.62 58.60 ± 12.88a 0.45 113.60 ± 34.04a 0.83
 SWT 87.27 ± 14.64b 192.20 ± 35.55a 59.20 ± 13.41a 113.13 ± 32.32a
6th month
 Placebo 97.64 ± 23.39a 0.01 192.36 ± 32.85a 0.88 57.51 ± 12.75a 0.23 113.84 ± 32.21a 0.48
 SWT 85.89 ± 17.86b 192.73 ± 36.25a 59.13 ± 12.31a 112.84 ± 33.68a
Table 5 The hepatic marker enzymes in plasma of placebo 
and SWT treated healthy subjects
Values were expressed as mean ± SD (n = 55). Data within the same column 
of each group bearing different superscript letters were significantly different 
(p < 0.05)
* Student’s t test was used to assess statistical significance between placebo and 
Si Wu Tang (SWT)
Group GPT (U/L) p value* GOT (U/L) p value*
Baseline
 Placebo 19.05 ± 0.27a 0.92 20.61 ± 6.37a 0.91
 SWT 19.00 ± 0.93a 20.67 ± 6.46a
3rd month
 Placebo 19.27 ± 0.46a 0.68 20.11 ± 6.63a 0.72
 SWT 19.44 ± 0.94b 20.35 ± 7.74a
6th month
 Placebo 19.47 ± 0.79a 0.76 21.42 ± 7.17a 0.65
 SWT 19.56 ± 15.11b 21.16 ± 7.83a
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placebo and SWT groups. In the placebo group, no sig-
nificant changes were noted in any of the skin parame-
ters. No marked changes in skin elasticity, moisture, or 
melanin content were observed between baseline and 
6 months in the SWT group; however, a significant incre-
ment in erythema was noted in the facial skin (261.12–
275.55), whereas the skin surface water loss (5.90–4.87 g/
m2/h), sebum content (163.86–144.96 μg/cm2), and skin 
wrinkles (37.41–35.23) in the arm were substantially 
lower than those at baseline.
Table 7 shows the skin examination results in the pla-
cebo- and SWT-treated participants with and without 
a menstrual cycle. In the placebo group, no significant 
changes were noted in any of the skin parameters. No 
significant changes in skin elasticity, moisture, or mela-
nin content from baseline to 6 months were observed in 
the SWT-treated group in either the face or arm region. 
A notable elevation in erythema was noted in the facial 
skin (295.57–303.66; P =  0.031) in participants without 
a menstrual cycle; however, participants with a men-
strual cycle showed elevated erythema in both the facial 
(238.16–256.80; P = 0.022) and arm skin (206.65–222.97; 
P = 0.021). The skin surface water loss (5.97–5.06 g/m2/h; 
P = 0.025), sebum content (164.91–138.00 μg/cm2), and 
skin wrinkles (37.22–34.95; P = 0.032) in the arms of par-
ticipants with a menstrual cycle were substantially lower 
than those of baseline.
SWT increased the blood circulation to maintain 
hemostasis via stimulation of hematopoietic stem cells 
[41] and thus increased the immune response and ele-
vated the erythema condition. The elevation in the blood 
cell concentration may alter various hormone levels (e.g., 
Fig. 2 The Abdominal ultrasonic image of SWT treated healthy participants. a–c represented participant no. 3, 9 and 28 at baseline with mild fatty 
liver, gall bladder stone and splenomegaly respectively (indicated with arrow mark). d–f represents participant no. 3, 9 and 28 at 6th month of SWT 
treatment with normal inference (no signs of fatty liver, gall bladder stone and splenomegaly)
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antidiuretic hormone), which may decrease the skin 
surface water loss, control water retention, and stabi-
lize collagen production, thus decreasing skin wrinkles 
with elevated antioxidation activity on the skin surface 
of SWT-treated participants. Because SWT eases men-
strual cycle-related dysfunction, it may also boost blood 
circulation throughout the body and hence decrease 
skin-related dysfunctions by flushing out toxins in the 
skin. However, we also encountered a controversial result 
showing decreased sebum secretion in SWT-treated 
participants with a menstrual cycle. Ohta et  al. [42] 
reported that the skin sebum content was reduced after 
menopause in women, but the exact mechanism remains 
unknown. Lignsticum chuanxiong exhibited skin regen-
eration effects in patients with eczema and psoriasis [43]. 
SWT inhibited mast cell activation and thus suppressed 
Table 6 Skin examination in placebo and SWT treated all healthy subjects
Values were expressed as mean ± SD (n = 55). Data within the same column of each group sharing different superscript letters (a, b) were significantly different 
(p < 0.05)
Parameters Duration Placebo SWT
Face Arm/T-zone Face Arm/T-zone
Skin elasticity Baseline 0.806 ± 0.09a 0.885 ± 0.08a 0.806 ± 0.09a 0.883 ± 0.05a
6th month 0.805 ± 0.08a 0.874 ± 0.05a 0.814 ± 0.08a 0.805 ± 0.08a
Skin moisture Baseline 45.18 ± 10.75a 49.45 ± 9.66a 45.18 ± 10.75a 49.45 ± 9.66a
6th month 45.20 ± 9.86a 49.40 ± 10.83a 45.11 ± 8.62a 49.08 ± 9.49a
Surface water loss (g/m2/h) Baseline 9.43 ± 1.07a 5.90 ± 0.66a 9.43 ± 1.07a 5.90 ± 2.36a
6th month 9.34 ± 1.54a 5.52 ± 1.79a 9.14 ± 3.73a 4.87 ± 1.61b
Sebum (μg/cm2) content Baseline 71.46 ± 6.42a 163.86 ± 26.46a 71.46 ± 6.42a 163.86 ± 26.46a
6th month 64.02 ± 5.34a 152.76 ± 28.37a 62.06 ± 6.22a 144.96 ± 22.95b
Skin melanin index Baseline 191.47 ± 40.59a 185.76 ± 28.02a 191.47 ± 40.59a 185.76 ± 31.02a
6th month 193.68 ± 34.78a 185.22 ± 28.78a 190.95 ± 41.44a 184.91 ± 40.51a
Skin erythema index Baseline 261.12 ± 49.07a 227.68 ± 35.96a 261.12 ± 79.07a 227.68 ± 55.96a
6th month 266.37 ± 47.55a 229.40 ± 34.88a 275.55 ± 72.11b 239.06 ± 57.14a
Skin wrinkles Baseline 34.84 ± 2.82a 37.41 ± 3.89a 34.84 ± 2.82a 37.41 ± 3.89a
6th month 34.97 ± 3.42a 37.02 ± 3.04a 34.06 ± 5.70a 35.23 ± 3.20b
Table 7 Skin examination in placebo and SWT treated healthy subjects with and without menstrual cycle
Values were expressed as mean ± SD (n = 55). Data within the same column of each group sharing different superscript letters (a, b) were significantly different 
(p < 0.05)
Parameters Duration Placebo Si Wu Tang (SWT)
Without menstrual cycle With menstrual cycle
Face Arm/T-zone Face Arm/T-zone Face Arm/T-zone
Skin elasticity Baseline 0.806 ± 0.09a 0.883 ± 0.05a 0.774 ± 0.08a 0.856 ± 0.06a 0.827 ± 0.09a 0.901 ± 0.05a
6th month 0.805 ± 0.08a 0.874 ± 0.05a 0.769 ± 0.08a 0.864 ± 0.06a 0.843 ± 0.06a 0.895 ± 0.06a
Skin moisture Baseline 45.18 ± 10.75a 49.45 ± 9.66a 44.83 ± 10.75a 47.42 ± 9.20a 45.41 ± 10.40a 50.80 ± 9.86a
6th month 45.20 ± 9.86a 49.40 ± 10.83a 48.11 ± 8.62a 51.08 ± 9.94a 43.11 ± 8.62a 47.45 ± 9.09a
Surface water loss (g/m2/h) Baseline 9.43 ± 1.07a 5.90 ± 0.66a 10.02 ± 1.90a 5.81 ± 0.98a 9.04 ± 1.07a 5.97 ± 1.89a
6th month 9.34 ± 1.54a 5.52 ± 0.79a 9.83 ± 3.26a 4.59 ± 1.08a 9.34 ± 3.73a 5.06 ± 1.55b
Sebum (μg/cm2) content Baseline 71.46 ± 6.42a 152.86 ± 26.46a 68.82 ± 6.53a 162.27 ± 16.46a 73.24 ± 6.42a 164.91 ± 16.46a
6th month 64.02 ± 5.34a 163.76 ± 28.37a 58.00 ± 6.96a 155.41 ± 30.47a 71.42 ± 6.22a 138.00 ± 22.95b
Skin melanin index Baseline 191.47 ± 40.59a 185.76 ± 28.02a 201.02 ± 40.59a 204.27 ± 31.02a 185.10 ± 40.59a 173.41 ± 27.43a
6th month 193.68 ± 34.78a 185.22 ± 28.78a 202.80 ± 41.44a 203.29 ± 40.51a 183.05 ± 41.44a 172.65 ± 30.51a
Skin erythema index Baseline 261.12 ± 49.07a 227.68 ± 35.96a 295.57 ± 49.07a 259.23 ± 64.10a 238.16 ± 54.70a 206.65 ± 38.06a
6th month 266.37 ± 47.55a 229.40 ± 34.88a 303.66 ± 41.17b 263.21 ± 64.58a 256.80 ± 59.54b 222.97 ± 45.88b
Skin wrinkles Baseline 34.84 ± 2.82a 37.41 ± 3.89a 35.66 ± 3.15a 37.69 ± 4.96a 34.30 ± 2.48a 37.22 ± 3.05a
6th month 34.97 ± 3.42a 37.02 ± 3.04a 34.83 ± 3.03a 36.66 ± 3.92a 34.54 ± 3.61a 34.95 ± 2.65b
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the inflammatory response, proving useful for alleviation 
of cutaneous pruritus [6].
Figure  3 depicts the skin surface topography of the 
facial and arm skin of Participant 23 as viewed under 
ultraviolet light. Figure  3a, b represents the facial and 
arm skin of patients in the placebo group, who displayed 
less skin integrity; Fig.  3c, d shows the facial and arm 
skin of patients in the SWT group at 6  months, show-
ing improved skin integrity and texture. Elevated levels 
of free radicals are responsible for the weakening of elas-
tin and collagen, skin wrinkles, fragility, dull appearance, 
and aging [44]. Because SWT is a good antioxidant, it 
can effectively scavenge free radicals and thus probably 
improve skin elasticity and texture. Moreover, cnidilide 
and ligustilide (Rhizoma L.) are present in SWT and may 
be primarily involved in the inhibition of the skin inflam-
matory reaction and stimulation of blood circulation by 
altering sebum secretion [5, 7].
Conclusions
Oral administration of SWT for 6  months significantly 
improved the antioxidant level and thereby positively 
regulated the lipid profile, liver function, and skin integ-
rity and texture.
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